Cencora, Inc.

COR

Coresite Realty Corporation (COR) is a real estate investment trust (REIT) that owns, operates, and develops high-performance data centers.
It is a leading player in the digital infrastructure sector, providing critical connectivity and cloud access solutions to enterprise and network-dense customers.

$359.11 -1.12 (-0.31%)

Updated: February 19, 2026, 16:00 EST

Analyzed by Rockflow Bobby Quantitative Model āœ“ Updated Daily

Investment Opinion: Should I buy COR Today?

Based on a balanced assessment of COR's profile, this stock presents a compelling case for defensive investors willing to pay a premium for stability, but it carries significant risks for those seeking growth or value.

Technical Analysis indicates COR is trading with strong momentum near its 52-week high and has demonstrated lower volatility than the market. While this suggests relative stability, its proximity to the yearly peak also hints it may be overbought, presenting a near-term risk of consolidation or pullback.

Fundamentals are mixed. The company has impressively returned to profitability and shows high operational efficiency and returns on equity. However, these strengths are materially offset by concerning cash flow figures, high leverage reflected in its debt-to-equity ratio, and thin gross margins, indicating underlying financial strain.

Valuation is the most significant headwind. The stock appears substantially overvalued based on traditional metrics like P/E and Price-to-Book ratios, which are at elevated levels. This high price tag demands near-perfect execution for the stock to justify its current level.

Risk Assessment is moderate. The low beta offers a defensive characteristic, but this is tempered by the company's liquidity concerns and high financial leverage, which could amplify problems in an economic downturn.

Investment Recommendation

COR is a HOLD for existing investors but a cautious AVOID for new purchases at the current price. The combination of rich valuation, negative cash flow, and high debt outweighs its positive attributes of stability and recent profitability. A more attractive entry point would likely emerge on a significant price correction that better reflects the fundamental and liquidity risks. Investors should monitor the company's ability to translate its operational efficiency into sustained positive cash flow.

CTA Banner

COR 12-Month Price Forecast

RockFlow Model Forecast: Three Scenarios for 2026

Based on the provided analysis, here is a 12-month outlook for COR:

Over the next 12 months, COR's performance is likely to be driven by its ability to translate operational efficiency into sustained positive cash flow and manage its high debt load. The key catalyst would be a clear demonstration of improving cash flow generation, which could help justify its premium valuation. However, the primary risk remains its significant overvaluation coupled with financial leverage, making it highly vulnerable to any operational missteps or a broader economic slowdown that could strain its liquidity.

Given the substantial headwinds from its valuation and fundamentals, the stock appears poised for consolidation or a pullback to a more reasonable level. A target price is not specified, but a more attractive entry point would likely be significantly below the current price of $358.41 to better reflect the underlying risks.

Wall Street Consensus

Most Wall Street analysts are optimistic about Cencora, Inc.'s 12-month outlook, with consensus target around $359.11, indicating expected upside potential.

Average Target
$359.11
18 analysts
Implied Upside
+0%
vs. current price
Analyst Count
18
covering this stock
Price Range
$287 - $467
Analyst target range
Buy Buy
14 (78%)
Hold Hold
3 (17%)
Sell Sell
1 (6%)

Bulls vs Bears: COR Investment Factors

Overall, COR has investment potential but also faces challenges. Here are key factors to weigh before investing.

Bullish Bullish
  • Stock Outperformance: COR stock is outperforming its medical peers and hitting 52-week highs.
  • Strategic Acquisitions: Company is making major investments in animal health and oncology sectors.
  • Raised Long-Term Guidance: Cencora has raised its long-term adjusted EPS growth target to 10%-14%.
  • Institutional Confidence: Vanguard Group increased its stock position in the company by 4.1%.
  • Options Market Activity: Unusual options activity may predict a future price spike.
Bearish Bearish
  • Analyst Downgrade: Analysts downgraded the stock to 'hold,' causing a 4.3% price drop.
  • Insider Selling: The CEO sold over $1.8 million in company stock recently.
  • High Acquisition Spending: Large investments like the $5B OneOncology deal increase financial leverage.
  • Market Volatility: Recent stock price decline indicates potential investor skepticism.
Reward Banner

COR Technical Analysis

COR has demonstrated strong long-term performance despite some recent volatility, currently trading near its 52-week highs with relatively low volatility compared to the broader market.

The stock has shown mixed short-term performance, gaining 1% over the past month but declining 1.38% over three months, slightly underperforming the market by 1.82%. With a beta of 0.685, COR's price movements have been less volatile than the overall market during this period.

Currently trading at $358.41, COR sits in the upper quartile of its 52-week range ($237.71-$377.54), approximately 5% below its peak. The modest 11.95% maximum drawdown suggests the stock has maintained relatively stable momentum and could be approaching overbought territory given its proximity to the yearly high.

šŸ“Š Beta
0.69
0.69x market volatility
šŸ“‰ Max Drawdown
-11.9%
Largest decline past year
šŸ“ˆ 52-Week Range
$241-$378
Price range past year
šŸ’¹ Annual Return
+47.5%
Cumulative gain past year
Period COR Return S&P 500
1m +2.4% +1.0%
3m -1.7% +1.9%
6m +24.2% +6.5%
1y +47.5% +12.1%
ytd +6.0% +0.2%

COR Fundamental Analysis

Revenue & Profitability COR's quarterly revenue grew to $85.9 billion in Q1 2026 from $83.7 billion in Q4 2025. Profitability improved significantly, with net income swinging from a $340 million loss to a $560 million profit, and the net profit margin rising from negative -0.4% to 0.65%. Despite this improvement, gross margins remain thin at around 3.2%, indicating high cost pressures.

Financial Health The company maintains a high debt-to-equity ratio of 4.15, reflecting substantial leverage, though the debt ratio is low at 10.1%. Cash flow metrics are concerning, with negative operating cash flow per share (-$11.87) and a negative cash flow to debt ratio (-0.29), signaling potential liquidity strain despite solid interest coverage of 10.9x.

Operational Efficiency COR demonstrates strong returns on equity at 29.3%, driven by a high equity multiplier of 41.1x. Asset turnover is efficient at 1.1x, while fixed asset turnover is particularly robust at 35.1x. However, the negative operating cash flow and working capital cycle (-7.4 days) suggest efficiency gains may not yet be translating into sustainable cash generation.

Quarterly Revenue
$85.9B
2025-12
Revenue YoY Growth
+5.5%
YoY Comparison
Gross Margin
3.6%
Latest Quarter
Free Cash Flow
$-0.6B
Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

RockFlow Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

Try Now & Get Tesla Stock Reward

Valuation Analysis: Is COR Overvalued?

Based on the provided metrics, COR appears significantly overvalued. The trailing P/E of 42.7 and forward P/E of 29.3 are exceptionally high, suggesting investors are paying a large premium for its earnings. This view is reinforced by an extremely high Price-to-Book ratio of 33.4 and a very elevated EV/EBITDA of 68.9, both indicating the stock price is not well-supported by its asset base or operational cash flow. The negative PEG ratio, while potentially a red flag due to negative growth expectations, cannot be reliably interpreted in this context.

A peer comparison cannot be conclusively performed as industry average data is unavailable. Therefore, the assessment of overvaluation is based solely on the absolute levels of the valuation multiples, which are high by almost any conventional standard. An analysis against sector-specific benchmarks would be necessary to confirm this preliminary conclusion.

PE
42.7x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -45Ɨ-3303Ɨ
vs. Industry Avg
N/A
Industry PE ~N/AƗ
EV/EBITDA
68.9x
Enterprise Value Multiple

Investment Risk Disclosure

Volatility Risk: COR exhibits lower volatility risk compared to the broader market, with a Beta of 0.685 suggesting it is approximately 31.5% less volatile than the market benchmark. However, this reduced volatility comes with potential limitations for investors seeking market-matching returns, as COR may fail to fully capture strong market upswings during periods of broad market growth due to its lower Beta. Additionally, the stock has experienced a maximum drawdown of 11.95% over the past year, aligning with general downside risk ranges.

Other Risks: COR currently shows no significant short-term risks, as indicated by the absence of measurable short interest. Nevertheless, investors should remain vigilant regarding broader liquidity risks that remain inadequately assessed in this analysis.

FAQs

Is COR a good stock to buy?

Neutral to slightly bearish for now. While COR shows strong operational metrics and positive analyst sentiment, its extremely high valuation multiples (P/E of 42.7, P/B of 33.4) create significant risk, especially given its negative cash flow and high leverage. This stock may suit aggressive, long-term growth investors who believe in its strategic acquisitions, but value-conscious or risk-averse investors should wait for a more attractive entry point or stronger cash generation.

Is COR stock overvalued or undervalued?

Based on the provided metrics, COR appears overvalued. The stock trades at extremely elevated multiples, including a trailing P/E of 42.7 and a price-to-book (PB) ratio of 33.4, which are high by almost any standard. These metrics suggest the market is pricing in exceptionally high future growth, which is not yet supported by the company's thin profit margins (0.65%) and negative operating cash flow. The negative PEG ratio further complicates the growth picture, indicating that its high P/E is not justified by its earnings growth trajectory.

What are the main risks of holding COR?

Based on the provided information, here are the key risks of holding COR:

1. Financial Liquidity Risk: Despite strong profitability metrics, negative operating cash flow and a negative cash flow to debt ratio indicate a fundamental strain on the company's ability to generate cash to service its substantial debt load. 2. High Financial Leverage Risk: The extremely high debt-to-equity ratio of 4.15 exposes the company to significant risk if interest rates rise or if earnings decline, potentially amplifying losses. 3. Valuation and Momentum Risk: The stock is trading near its 52-week high, which increases its susceptibility to a price correction, especially if future growth fails to meet high investor expectations.

What is the price forecast for COR in 2026?

Of course. Here is a professional forecast for COR stock through 2026.

COR Stock Forecast Through 2026

1. Target Price Range: * Base Case (2026): $250 - $280. This scenario assumes a necessary correction from current overvaluation as high leverage and thin margins pressure the multiple. * Bull Case (2026): $380 - $400. This is contingent on COR successfully translating its high operational efficiency into sustained positive cash flow and reducing its debt burden, justifying its current premium.

2. Key Growth Drivers: * Sustained Positive Cash Flow Generation: The most critical catalyst. A reversal from negative to strong positive operating cash flow is needed to alleviate liquidity concerns and support the valuation. * Debt Management and Reduction: Successfully lowering the high debt-to-equity ratio (4.15) would significantly de-risk the investment profile and reduce financial strain. * Margin Expansion: Improving upon the thin 3.2% gross margin through operational efficiencies or pricing power is essential for driving meaningful profit growth.

3. Main Assumptions: * The broader economy avoids a significant recession that would strain its leveraged balance sheet. * Management executes effectively on its operational strategy to convert efficiency metrics (high ROE, asset turnover) into tangible cash flow. * Current revenue growth trends continue, but investor focus shifts from top-line growth to profitability and balance sheet health.

4. Forecast Uncertainty: * This forecast carries high uncertainty. The primary risk is the stock's current high price combined with negative cash flow and high leverage, making it highly vulnerable to any operational missteps or shifts in market sentiment.

In summary, while COR shows impressive operational efficiency, its path to 2026 is bifurcated. Without a rapid improvement in cash flow and debt management, a significant price correction is the more probable outcome. A bull case depends entirely on the company overcoming these substantial financial headwinds.